Restatement Cleared and Leverage Ahead of Plan at 3.3x, But a Cut 2026 Guide and Softening Take 5 Traffic Reset the Bar

Results vs. Consensus

Quality of Beat/Miss

• Revenue: Solid. Continuing-ops revenue of $460.1M grew 7.7% year-over-year and topped the modest consensus. But the headline overstates momentum: consolidated same-store sales were just +0.5%, and the growth is unit-driven against a portfolio that has shed the car wash businesses.
• Margins: Better than they read at 24.3%. Q4 operating expenses fell $29.5M year-over-year on lower stock/performance comp, lower bad-debt expense, and the lapping of prior-year divestiture losses. Adjusted EBITDA grew 7.3%, a genuine improvement, though the quarter benefits from favorable comparisons rather than underlying acceleration.
• EPS: The beat is real but the bar was low. Adjusted EPS of $0.34 cleared a depressed $0.23 consensus that had been marked down through the delay. The more important number is the forward one: the 2026 adjusted EBITDA guide implies a decline before adding back restatement costs, and management is deliberately not adding them back.

Segment Performance

Take 5 Oil Change

Take 5 posted its 22nd straight comp quarter, but the deceleration is now unmistakable: Q4 same-store sales of +3.7% is well down from the mid-to-high single digits earlier in 2025, and management explicitly flagged traffic moderation heading into 2026 concentrated in newer and value-oriented customers. For the full year, Take 5 grew comps 6.2%, added 161 units, and delivered a 34.4% EBITDA margin, in line with the mid-30s framework. The forward tell is the peer comparison: after twelve quarters of outperforming its larger public peer, Take 5 is guided to underperform on concept comps by nearly 400bps in Q1 2026.

"We're seeing a little bit of moderation in traffic coming into this year. And that's really with 2 specific cohorts of customers, a little bit with newer customers and then with more value-oriented customers... the team is really focused on value proposition and focusing on long-term customer relationships." — Danny Rivera, President and CEO

Assessment: This is the first material challenge to the load-bearing bull pillar since initiation. Average check and non-oil attachment remain strong, so this is a traffic story, not a pricing one, but softening traffic in the value cohort is precisely the leading indicator to watch in a business whose whole case rests on Take 5 compounding. The 2-year stack (~12.5%) is still healthy, and one soft print does not break the thesis, but the pillar moves from unambiguous strength to something that needs monitoring.

Franchise Brands

The franchise segment slipped back to a -1.0% Q4 comp on continued collision softness, with EBITDA roughly flat at $42.4M. For the full year it held a 62.7% margin and again did its designated job as the high-margin cash generator funding deleveraging, even as revenue declined 3.5%. Management is guardedly constructive on collision normalizing through 2026 while remaining cautious on the discretionary Maaco brand, where the retail side is showing early signs of a trajectory change on better execution.

"Franchise Brands, I don't want to say regardless of its sales trajectory, but whether it's up a couple of hundred basis points or down still flows through strong profit." — Michael Diamond, CFO

Assessment: The segment continues to perform its cash-generation role well, which is what matters for the deleveraging thesis. Collision normalization is a genuine tailwind into 2026 that partly offsets the Take 5 deceleration. This bear point remains contained.

Auto Glass Now (New Reportable Segment)

The resegmentation that followed the car wash exits promoted the previously incubating glass business into a standalone reportable segment. Auto Glass Now grew full-year revenue and EBITDA 9% and 105% respectively, with margin improving 470bps to 10%, and is now described as the second-largest operator in the industry with retail, commercial, and insurance channels.

Assessment: AGN graduating to a reportable segment is a meaningful signal that the optionality flagged at initiation is starting to become real, though at a $3.2M quarterly EBITDA it is still immaterial to consolidated results. Its 470bps of margin improvement and doubling of EBITDA make it the clearest new growth lever, but it is a multi-year build, not a 2026 driver.

Key Topics & Management Commentary

Overall Management Tone: Notably more forthcoming and accountable than in prior quarters, opening with an unprompted four-part framing of the restatement (what happened, root cause, why now, prevention) rather than deflecting. The posture on the balance sheet and portfolio was confident and evidence-backed, while the tone on Take 5 traffic and the 2026 guide was appropriately sober. The one area where confidence outran precision was the assertion that the $35-$45M of restatement costs are cleanly non-recurring, which the market will only believe once it is in the rear-view mirror.

The Restatement: Root Cause and Remediation

Management devoted the top of the call to the restatement, tracing it to the 2022-2023 acquisition and integration wave (car wash, glass, the Driven Advantage marketplace) that outran back-office controls, compounded by a multi-ERP-to-Oracle consolidation that went live mid-2024. The errors span cash overstatement (largely at AGN), understated lease assets/liabilities, an expense-classification correction, an accounts-payable understatement that raised Take 5 COGS in 2023, and accounts-receivable reserve issues.

"During our 2025 year-end closing process, we identified 3 issues requiring further review... As we review these matters further, we determined that there were material errors requiring the restatement of prior financial statements... we would prioritize accuracy and completeness over speed." — Danny Rivera, President and CEO

Assessment: The disclosure was as complete and accountable as a restatement disclosure gets, and the fact that the new CFO and CAO surfaced the issues is a mark in favor of the strengthened finance function rather than against it. But a material-weakness restatement is a real governance blemish that raises the risk premium on the equity and will keep some investors on the sidelines until a clean audit cycle passes. It does not break the thesis; it enlarges the discount.

Deleveraging Ahead of Plan to 3.3x

The clearest positive was the balance sheet. The January IMO sale for roughly €411M funded more than $470M of additional paydown, taking pro forma net leverage to 3.3x with debt now 100% securitized fixed-rate at a 4.3% weighted-average rate.

"In January, we used proceeds from the sale of our International Car Wash business to fully extinguish our 2019-2 senior notes... more than $470 million of debt repaid in total. Pro forma for the transaction, our net leverage ratio is 3.3x." — Michael Diamond, CFO

Assessment: This is the pillar carrying the rating. Reaching 3.3x puts the 3.0x-by-year-end-2026 target well within reach and materially de-risks the equity regardless of the near-term operating softness. Interest expense guided to ~$90M for 2026 is a large tailwind versus the ~$120M 2025 run-rate. The deleveraging story is arguably better than the market gave it credit for on the day.

The 2026 Guide Cut and Whether It Is a New Baseline

The 2026 outlook was reset materially lower, and management was pressed on whether the depressed EBITDA is structural or a one-off restatement-cost year.

"That $430 million to $460 million incorporates $35 million to $45 million of restatement costs that we view as nonrecurring... we view $35 million to $45 million, that's 2026 expense that we don't see recurring once we get into 2027." — Michael Diamond, CFO

Assessment: Backing out the restatement costs, underlying 2026 EBITDA is roughly flat-to-modestly-up rather than down, so the guide is less alarming than the headline number suggests. But the choice not to add the costs back is a conservative, credibility-preserving one, and the market is right to wait for proof that 2027 snaps back before paying for it. The near-term earnings are depressed for a knowable, temporary reason, which is the crux of the Hold.

Oil Supply, Cost Pass-Through, and Input Management

Multiple questions probed lubricant supply security and the ability to pass through rising oil costs. Management expressed no supply concern (over a month of supply, strong procurement scale) and detailed the levers, noting base oil is at most half of oil COGS and that waste-oil reclamation values move with oil prices to partly offset.

"An increase in $1 of a barrel of oil does not necessarily flow through 1:1 for cost... Base oil price is at most 50% of the cost of oil... that, therefore, gives us some flexibility to figure out how we can, if we choose to pass along price." — Michael Diamond, CFO

Assessment: A reassuring, detailed answer that defuses input-cost concern for 2026. Take 5's scale in procurement and the reclamation offset are genuine advantages, and the ability to pass through price sits in reserve if needed. Not a thesis driver, but it removes a tail risk.

Guidance & Outlook

The 2026 framework pairs modest top-line growth with an adjusted EBITDA range that declines on a headline basis but is roughly flat once the $35-$45M of non-recurring restatement costs is isolated. Same-store sales of flat to 2% reflects continued collision/Maaco caution and Take 5 moderation. The standout positive is interest expense dropping to ~$90M on the deleveraging, and management guided the first half to contribute less than 50% of full-year EBITDA as restatement costs weigh on Q1-Q2. Preliminary Q1 2026 was pre-announced: consolidated comps of 1.9%-2.1%, Take 5 comps of 4.3%-4.5%, revenue of $475M-$485M, and adjusted EBITDA moderately lower year-over-year.

Implied 2026 shape: A back-half-weighted year with depressed first-half earnings for a temporary reason. To hit the EBITDA range, Take 5 must stabilize traffic while collision normalizes and AGN keeps scaling. Free cash flow of $125M-$145M, all directed at debt, is what carries leverage to 3.0x.

Guidance style: Conservative and transparent. Refusing to add back restatement costs, committing to quarterly disclosure of the spend, and pre-announcing Q1 all point to a management team managing credibility carefully after a difficult episode.

Analyst Q&A Highlights

Deceleration After Q1 and the Drivers Behind It

The opening exchange pressed on whether the guided post-Q1 deceleration is a comparison issue, a macro issue, or something in the underlying business.

Q: "The midpoint of your comp guide assumes a deceleration throughout the remainder of the year after the first quarter... Is that more of a function of more difficult comparisons? Or do you think it's more attributable to the macro? Or is there something else in the underlying business?"
— Phillip Blee, William Blair

A: "We continue to be conservative in our approach towards the Collision and the Maaco businesses... From a Take 5 perspective... we have seen a little bit of moderation headed post Q1 into Q2 of this year." — Michael Diamond, CFO

Assessment: The candid admission of Take 5 moderation, rather than hiding behind comparisons, is the most consequential disclosure of the call. It confirms the deceleration is partly demand-driven, not purely optical, which is exactly what the bear case needs to escalate.

Competitive Intensity and Underperforming the Peer

A pointed line of questioning noted that after twelve quarters of outperforming its larger public peer, Take 5 is now guided to underperform on concept comps by nearly 400bps, and asked whether restatement distraction, macro, or something else was to blame.

Q: "For the 12 quarters prior to Q4, Take 5 materially outperformed its larger public peer, but that reversed in Q4 and now Q1 where it's expected to underperform in concept by nearly 400 bps. So what's driving that? Is that simply just taking the eye off the ball while prioritizing the restatement?"
— Brian McNamara, Canaccord Genuity

A: "Q1, we're looking to come in at about 4.3% to 4.5%. That's about 12.5%-ish on a 2-year basis... we are seeing a bit of moderation in traffic with Take 5 coming into 2026... one hot day doesn't make a summer, but we're seeing that moderation right now, and the team is taking the appropriate actions." — Danny Rivera, President and CEO

Assessment: Management leaned on the 2-year stack to reframe the single-quarter underperformance, which is a fair defense, but did not fully rebut the competitive-share concern. The "one hot day doesn't make a summer" framing is a tell that management itself is watching this closely.

Decomposing the Flat-to-2% Comp Guide

Questioning sought to decompose the 2026 comp guide by segment and understand why franchise and AGN might be slowing if Take 5 is growing.

Q: "The 1% comp outlook for '26, could you decompose the contribution from each business? And then if Take 5 is growing that may imply that franchise and AGN are slowing."
— Skylar Tennant (for Simeon Gutman), Morgan Stanley

A: "Our Collision business outweighs the impact on same-store sales versus profit given the royalty structure... if you think about what would drive to the low end of the range, it would be continued pressure on the overall collision industry... AGN is an incubation period... even significant growth at AGN will contribute modestly to the overall same-store sales growth." — Michael Diamond, CFO

Assessment: A useful clarification that the consolidated comp is disproportionately a collision story because of the royalty/system-sales weighting. It reinforces that the headline comp is a poor proxy for profit, which cuts both ways for the thesis.

Where 2026 EBITDA Growth Comes From

An exchange probed that, adjusting for the ~$40M non-recurring cost, implied underlying 2026 EBITDA is up roughly $35M, and asked where that growth originates.

Q: "If we adjust that $40 million nonrecurring cost at the midpoint, it implies that next year, EBITDA would be up about $35 million. So can you just break out where that growth is coming from?"
— Skylar Tennant (for Simeon Gutman), Morgan Stanley

A: "We expect to see mid-single-digit growth for Take 5 going forward... AGN continues to be a good growth platform. And then Franchise Brands... whether it's up a couple of hundred basis points or down still flows through strong profit... working hard to be efficient on our G&A and make sure that flows through." — Michael Diamond, CFO

Assessment: The answer confirms the important point that underlying EBITDA grows in 2026 ex-restatement costs, which is the analytical case for looking through the depressed headline. It also anchors Take 5 at mid-single-digit growth, consistent with the moderation narrative.

Portfolio Strategy and Further M&A/Divestitures

An exchange asked whether the restatement process prompted any strategy or portfolio changes.

Q: "Any color on strategy changes contemplated during this process in terms of either the outlook on M&A or divestitures from here?"
— Robby Ohmes, Bank of America

A: "We've divested 3 companies in the last 18 months. We view portfolio management as one of the levers at our disposal... we want to be disciplined about the portfolio, and we want to make sure that we stay focused on nondiscretionary North American automotive services businesses." — Danny Rivera, President and CEO

Assessment: A clear reaffirmation of active portfolio management with no strategy change. It keeps open the possibility of further monetization to accelerate deleveraging while confirming the North American non-discretionary focus is settled.

Corporate Overhead as an Efficiency Opportunity

A recurring line of questioning from investors pressed on whether corporate overhead is a cost-efficiency opportunity.

Q: "Maybe you could just double-click on that [corporate overhead] expense line for some investors that may see it as an opportunity for some further cost efficiencies."
— Marvin Fong, BTIG

A: "In the '25 SG&A number, you've got, call it, $40 million that's related to the portfolio management activities over the last 18 months... that is far more tied to the portfolio management activities... as opposed to true dollars for hands-on keyboards." — Michael Diamond, CFO

Assessment: The disclosure that ~$40M of 2025 SG&A was transaction/portfolio-related rather than run-rate is genuinely useful for normalizing the cost base. It supports the view that overhead looks inflated for temporary reasons and offers a self-help lever as those costs roll off.

What They're NOT Saying

1. A named material-weakness remediation timeline: Management described strengthening the finance function but did not commit to when internal controls will be deemed remediated or when a clean audit opinion is expected, leaving the governance overhang open-ended.
2. The competitive share loss to the larger peer: Pressed on underperforming its public peer by ~400bps, management reframed to the 2-year stack but did not directly address whether it is losing share, why, or what specifically reverses it beyond "value proposition."
3. How deep the value-cohort traffic softening goes: The traffic moderation was acknowledged but not sized. There is no quantification of how much of the guided Take 5 deceleration is the value cohort versus the tough lap.
4. Post-3.0x capital allocation, still unresolved: Three quarters after first hinting at it, management again deferred a concrete framework for what happens to free cash flow once 3.0x is reached, keeping the eventual re-rating catalyst undefined.

Market Reaction

• Pre-print setup: DRVN closed at $14.24 the day before the delayed report, already well below its 2025 highs after a year of de-rating through the restatement delay and consumer softness.
• Reaction-day session: With the release and 8:30 AM ET call landing before the open, DRVN fell to $13.23 at the close, a -7.1% move on the day, the worst single-session reaction across the four quarters covered.

The sell-off is a rational response to the combination that mattered most: a materially lower 2026 EBITDA guide and the first explicit acknowledgment of Take 5 traffic softening, which together outweighed the ahead-of-plan deleveraging and the completed restatement. The market chose to price the deteriorating forward operating picture over the improved balance sheet, a reasonable prioritization when the core growth engine shows its first crack. That the stock did not fall further suggests the deleveraging and the low pre-print base provided a floor.

Street Perspective

Debate: Is the Restatement a Governance Red Flag or a Cleared Overhang?

Bull view: The restatement is now behind the company, the errors were non-cash and traced to a knowable acquisition-era controls gap, and the new CFO/CAO surfacing them is evidence the finance function is stronger; the overhang is lifting.

Bear view: A material-weakness restatement spanning multiple years and financial statements is a serious governance failure that warrants a permanent risk premium and keeps quality-focused investors away until a clean audit cycle passes.

Our take: Between the two, but closer to the bulls on substance and the bears on timing. The disclosure was complete and the root cause is contained, but trust is rebuilt over quarters, not on the filing date. The right posture is to acknowledge the overhang is lifting while demanding the discount stay until the controls are demonstrably remediated.

Debate: Does Take 5 Traffic Softening Break the Thesis?

Bull view: A single soft quarter against a tough lap, with average check and attachment still strong and a 2-year stack near 12.5%, is noise; Take 5 remains a mid-single-digit compounder with a long unit runway to 2,500 stores.

Bear view: Going from twelve quarters of peer outperformance to a ~400bps underperformance, with traffic softening specifically in the newer and value cohorts, is the leading edge of maturing unit economics and rising competition, and the entire thesis rests on this one segment.

Our take: This is the crux, and it is genuinely two-sided. The 2-year stack and intact check/attachment argue the bulls are right that it is early, but the concentration in the value cohort and the peer reversal are exactly the signals that would precede a structural deceleration. We do not think it breaks the thesis yet, but it is no longer a pillar we can label unambiguous strength, and it is the single most important thing to watch next quarter.

Debate: Is Deleveraging Enough to Support the Stock?

Bull view: At 3.3x pro forma and heading to 3.0x with interest expense dropping to ~$90M, the balance-sheet repair alone transfers meaningful value to equity and provides a floor under a de-rated stock.

Bear view: Deleveraging with a decelerating core and a depressed 2026 guide is the classic value-trap setup; the equity does not re-rate on leverage alone if EBITDA is going sideways.

Our take: The deleveraging is the reason the stock has a floor and the reason we are not bearish. But it is also, three quarters running, insufficient on its own for a re-rating. The stock needs Take 5 traffic to stabilize before the balance-sheet story converts into upside.

Model Update Needed

Valuation impact: The lower 2026 EBITDA guide reduces near-term earnings, but backing out the temporary restatement costs leaves underlying EBITDA roughly flat, and the interest-expense tailwind supports EPS. On a ~$1.20 adjusted EPS midpoint against a de-rated stock, valuation is not demanding, but the re-rating still requires Take 5 traffic to stabilize and the post-3.0x capital-allocation framework to materialize.

Thesis Scorecard Post-Earnings

Overall: Thesis weakened versus the standing view, on balance. The deleveraging pillar strengthened and refinancing risk is essentially retired, but the core Take 5 pillar was challenged for the first time and the restatement crystallized a governance bear point. The net is a business that is financially safer but operationally more uncertain than a quarter ago.

Action: Hold. The 7% sell-off already discounts the guide cut and the restatement, and the ahead-of-plan deleveraging plus a low base cap the downside. But the Take 5 traffic crack is the decisive watch item; a second quarter of value-cohort softening would tip the balance toward Underperform, while stabilization plus the post-3.0x capital plan would be the upgrade path.